Metformin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Metformin is the first-line oral medication for type 2 diabetes mellitus. It lowers blood glucose by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It is one of the most widely prescribed diabetes medications worldwide and has an extensive safety profile spanning decades of clinical use.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Metformin is the first-line oral medication for type 2 diabetes mellitus. NutriStack rates the supporting evidence as strong. Common adult dosing is 500–2,550 mg daily in divided doses (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete vitamin b12, folate. This profile indexes 13 sources.
- Nausea and vomiting
- Diarrhea
- Abdominal bloating and cramping
- Severe renal impairment (eGFR < 30 mL/min/1.73 m²)7
- Metabolic acidosis including diabetic ketoacidosis
The bottom line
Evidence rating strong. Most-documented uses: lowers fasting and postprandial blood glucose, reduces hba1c by 1.0–1.5%, weight neutral or modest weight loss. 13 sources indexed (2016–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Activates AMP-activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and increases glucose uptake in skeletal muscle. Also inhibits mitochondrial complex I in hepatocytes, reducing ATP production and shifting the cell toward catabolic pathways. Additionally decreases intestinal absorption of glucose and improves insulin receptor signaling.
Dosing & protocol.
Take with meals to reduce gastrointestinal side effects. Extended-release tablets should be swallowed whole.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Vitamin B12
SignificantMetformin impairs calcium-dependent uptake of the intrinsic factor-B12 complex in the terminal ileum, lowering B12 absorption during long-term use.
Folate
ModerateLong-term metformin use is associated with lower folate status, likely through impaired intestinal absorption and altered enterohepatic handling.
Full safety detail.
Side effects
- Nausea and vomiting
- Diarrhea
- Abdominal bloating and cramping
- Metallic taste
- Vitamin B12 deficiency with long-term use
- Lactic acidosis (rare but serious)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
8- 1Influence of Metformin on Exercise Metabolism and Capacity: A Systematic Review and Meta-AnalysisPMIDGrammer EE, Stahl ME, Ortiz de Zevallos J et al. · American journal of physiology. Endocrinology and metabolism · 2026
Grammer EE, Stahl ME, Ortiz de Zevallos J et al.. Influence of Metformin on Exercise Metabolism and Capacity: A Systematic Review and Meta-Analysis. American journal of physiology. Endocrinology and metabolism. 2026
- 2Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trialsPMIDKelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO et al. · Endocrine · 2025
Kelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO et al.. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine. 2025
- 3The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-AnalysisPMIDPeng TR, Chen JA, Lee JA et al. · Schizophrenia bulletin · 2025
Peng TR, Chen JA, Lee JA et al.. The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis. Schizophrenia bulletin. 2025
- 4Potential Efficacy of Metformin for Age-Related Macular Degeneration: A Systematic Review and Meta-AnalysisPMIDHuh MD, Le SN, O'Brien KS et al. · Ophthalmology science · 2025
Huh MD, Le SN, O'Brien KS et al.. Potential Efficacy of Metformin for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Ophthalmology science. 2025
- 5Association of metformin use and cancer incidence: a systematic review and meta-analysisPMIDO'Connor L, Bailey-Whyte M, Bhattacharya M, Butera G et al. · Journal of the National Cancer Institute · 2024
Metformin use was associated with reduced incidence of several cancer types, particularly colorectal and hepatocellular carcinoma, though residual confounding cannot be excluded
- 6The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trialsPMIDMelin J, Forslund M, Alesi S et al. · European journal of endocrinology · 2023
Melin J, Forslund M, Alesi S et al.. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. European journal of endocrinology. 2023
- 7Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysisPMIDTsapas A, Avgerinos I, Karagiannis T, Malandris K et al. · Annals of Internal Medicine · 2020
Metformin remains a foundational therapy for type 2 diabetes; SGLT2 inhibitors and GLP-1 receptor agonists showed superior cardiovascular and renal outcomes when added to metformin background therapy
- 8Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysisPMIDMaruthur NM, Tseng E, Hutfless S, Wilson LM et al. · Annals of Internal Medicine · 2016
Metformin monotherapy effectively lowers HbA1c and is recommended as first-line therapy; it has advantages in cardiovascular risk factor reduction compared to most other diabetes medications
Reference material
5- 9UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865.Source linkedPMID
- 10Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002;346(6):393-403.Source linkedPMID
- 11Inzucchi SE et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the ADA and EASD. Diabetes Care. 2015;38(1):140-149.Source linkedPMID
- 12Masarwa R, Brunetti VC, Aloe S et al.. Efficacy and Safety of Metformin for Obesity: A Systematic Review. Pediatrics. 2021Source linkedPMID
- 13Melin J, Forslund M, Alesi S et al.. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. The Journal of clinical endocrinology and metabolism. 2024Source linkedPMID
Common questions.
Quick answers about Metformin, drawn from the data on this page.
What is Metformin?
Metformin is the first-line oral medication for type 2 diabetes mellitus. It lowers blood glucose by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It is one of the most widely prescribed diabetes medications worldwide and has an extensive safety profile spanning decades of clinical use.
What is Metformin used for?
Commonly cited benefits of Metformin include: Lowers fasting and postprandial blood glucose; Reduces HbA1c by 1.0–1.5%; Weight neutral or modest weight loss; Cardiovascular risk reduction in overweight patients; Low risk of hypoglycemia as monotherapy. NutriStack rates the overall evidence as strong.
What is a typical dose of Metformin?
A typical adult dose of Metformin is 500–2,550 mg daily in divided doses (as prescribed by your physician). The commonly recommended form is Extended-release tablet preferred for GI tolerability. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Metformin?
Reported side effects include nausea and vomiting, diarrhea, abdominal bloating and cramping, metallic taste, vitamin b12 deficiency with long-term use, lactic acidosis (rare but serious). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Metformin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Metformin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.